COVID Vaccine Stocks Plummet After FDA Memo Links Shots to Child Deaths

Vaccine stocks, including Moderna, BioNTech, Novavax, and Vaxcyte, dropped after an FDA memo linked COVID shots to at least ten child deaths. The memo signaled the agency is preparing to roll out tough restrictions on new vaccines for children, citing a "profound revelation" and acknowledging that COVID-19 vaccines have killed American children. Analysts weigh in on the memo's implications for vaccine stocks and regulatory overhang.